new and special drug
Atled (Fanregratinib) – Intrahepatic Cholangiocarcinoma | HongKong DengYue Medicine
Redemplo (Plozasiran) – FCS | HongKong DengYue Medicine
Yizekang (Izalontamab Brengitecan) – NPC/ESCC | HongKong DengYue Medicine
Qiyoukang (Gumokimab) – Plaque Psoriasis | HongKong DengYue Medicine
Adempas (Riociguat) – CTEPH/PAH | HongKong DengYue Medicine
Ariane (Rezvilutamide) – mHSPC | HongKong DengYue Medicine
Baiyueda (Sonrotoclax) – CLL/SLL/MCL | HongKong DengYue Medicine
Inlyta (Axitinib) – RCC | HongKong DengYue Medicine
VUMON (Teniposide) – Antineoplastic Agent | HongKong DengYue Medicine
ILUMETRI (Tildrakizumab) – Tlaque Psoriasis | HongKong DengYue Medicine
KESIMPTA (Ofatumumab) – Multiple Sclerosis | HongKong DengYue Medicine
Aimovig (Erenumab Injection) – Migraine | HongKong DengYue Medicine
Takhzyro lanadelumab-flyo injection – Hereditary Angioedema | HongKong DengYue Medicine
Cuprior (Trientrine Tetrahydrochloride) – Wilson’s Disease | HongKong DengYue Medicine
Entinostat Tablets – HDAC | HongKong DengYue Medicine
SOTYKTU (Deucravacitinib Tablets) – Psoriasis | HongKong DengYue Medicine
